Skip to main content

Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

Clinical Info HIV.gov logo
In affiliation with HIV.gov

Main navigation

  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Spanish

clinical info.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Interim Guidance for Covid-19 and Persons with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 
Drug Database

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 
Glossary

Glossary

Medical dictionary of HIV-related terms.
Glossary 
Resources

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Free Mobile Apps

Download these free applications for your iOS and Android devices.
ClinicalInfo Guidelines
Guidelines
Download ClinicalInfo Guidelines app on the AppStore
Download ClinicalInfo Guidelines app on GooglePlay
ClinicalInfo Glossary
Drug database
Download ClinicalInfo Glossary app on the AppStore
Download ClinicalInfo Glossary app on GooglePlay
ClinicalInfo Drug Database
Glossary
Download ClinicalInfo Drug Database app on the AppStore
Download ClinicalInfo Drug Database app onGooglePlay

Table 2. Treatment of AIDS-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)

  • Read more about Table 2. Treatment of AIDS-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)

Table 1. Prophylaxis to Prevent First Episode of Opportunistic Disease

  • Read more about Table 1. Prophylaxis to Prevent First Episode of Opportunistic Disease

Antiretroviral Dosing Recommendations in Patients with Renal or Hepatic Insufficiency

  • Read more about Antiretroviral Dosing Recommendations in Patients with Renal or Hepatic Insufficiency

Characteristics of CD4 Post-Attachment Inhibitor

  • Read more about Characteristics of CD4 Post-Attachment Inhibitor

Characteristics of the CCR5 Antagonist

  • Read more about Characteristics of the CCR5 Antagonist

Characteristics of the Fusion Inhibitor

  • Read more about Characteristics of the Fusion Inhibitor

Characteristics of Integrase Inhibitors

  • Read more about Characteristics of Integrase Inhibitors

Characteristics of Protease Inhibitors

  • Read more about Characteristics of Protease Inhibitors

Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

  • Read more about Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

  • Read more about Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Next page Next ›
  • Last page Last »

Connect with us

Facebook
Twitter
Instagram
Subscribe

Mobile Apps

Guidelines
Drug Database
Glossary

Footer menu

  • Home
  • About
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.